$KNRX

KNOREX Faces NYSE American Non-Compliance Notice Over Listing Standards

Knorex Ltd. (KNRX) received a non-compliance notice from NYSE American due to a $6.5M stockholders' deficit and four years of net losses. The company plans to submit a remediation plan by September 20, 2026, to regain compliance by February 21, 2028. Failure to meet milestones could lead to delisting.

Original reporting
Published Aug 27, 2026, 9:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 6:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
KNOREX Faces NYSE American Non-Compliance Notice Over Listing Standards — source image
Decision brief

The 30-second read

$KNRXBearishLow
01

Why it matters

The non‑compliance notice signals heightened financial risk and may trigger forced selling or a restructuring plan.

02

Market read

Compliance breach could lead to delisting, affecting price and investor confidence in similar microcaps.

03

What to watch

Potential for a reverse split or relocation to a foreign exchange could mitigate delisting risk.

Relevance 6/10Novelty 6/10Timing: immediate

Background

Knorex is an AI‑driven programmatic advertising platform listed on NYSE American.

Company-level read

Ticker impact

$KNRXBearishMedium confidence
Context

Knorex received a NYSE American non‑compliance notice due to a $6.5 M stockholder deficit and four years of losses, risking delisting.

Expected impact

Downward pressure until compliance is demonstrated or a rescue transaction occurs.

Evidence & confidence

Compliance failures historically trigger sharp price declines for small‑cap listings.

Market effects

Highlights compliance risk for ad‑tech microcaps on US exchanges.

May affect investor sentiment toward other small US‑listed tech firms.

Limited to niche ad‑tech and exchange compliance observers.

Counterpoint

If Knorex secures a strategic partner or capital raise quickly, the compliance issue could be resolved without major price drop.

Key entities

  • Knorex Ltd.

    AI‑powered ad‑tech provider facing listing compliance issues.

  • NYSE American

    Regulatory body issuing the compliance notice.

Related articles

$PHOSMed

First Phosphate shareholders could see reduced dilution risk, Noble says after SERV news

First Phosphate Corp. (PHOS) may face reduced equity dilution after Noble Capital Markets noted potential lower funding needs for its Bégin-Lamarche project, supported by Swiss Export Risk Insurance (SERV) and other financing. SERV could provide up to US$212.5 million, reducing the equity requirement to about US$82.5 million. Noble maintains an Outperform rating and $25.50 price target.

$AONHighAI 9/10

Aon raises $13.75 billion to support USI acquisition

Aon raised $13.75 billion in senior notes, guaranteed by its subsidiaries, with maturities from 2029 to 2056 and coupons ranging from 5.350% to 6.450%. The funds, approximately $13.4 billion after expenses, will support the USI Advantage Corp. acquisition and general corporate purposes. The notes include redemption protections tied to the deal's completion.